Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc. (formerly Ra Medical Systems, Inc.) filed this Current Report on Form 8-K on April 1, 2024. The filing announces the company's financial results for the quarter and full year ended December 31, 2023. The company is incorporated in Delaware and trades on the NYSE American under the symbol VTAK.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It serves as a notification that results for the period ended December 31, 2023, have been issued.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, or risk factors in the main text. It notes that the information furnished in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2023.
- Verify the company's current liquidity position and debt obligations as detailed in the attached press release.
- Confirm any forward-looking statements or guidance provided in the press release, as they are not present in the 8-K summary text.
- Note the legal disclaimer that the financial data in this filing is "furnished" and not "filed" under Section 18 of the Exchange Act.